NCT07467772 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT07467772
Title	Ph 2 Elacestrant in ER Positive Uterine Sarcomas
Recruitment	Not yet recruiting
Gender	female
Phase	Phase II
Variant Requirements	No
Sponsors	Dana-Farber Cancer Institute
Indications	uterine corpus adenosarcoma endometrial stromal sarcoma uterus perivascular epithelioid cell tumor uterus leiomyosarcoma
Therapies	Elacestrant
Age Groups:	adult \| senior
Covered Countries	USA

Facility	Status	City	State	Zip	Country	Details
Brigham and Women's Hospital		Boston	Massachusetts	02115	United States	Details
Dana Farber Cancer Institute		Boston	Massachusetts	02215	United States	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT07467772Clinical Trial Detail